BIOLASE, Inc. Quarterly report pursuant to Section 13 or 15(d)

Revenue Recognition (Tables)

3 Months Ended

Mar. 31, 2023

The opening and closing balances of the Company’s contract liabilities are as follows (in thousands):


	March 31,			December 31,
	2023			2022
Undelivered elements (training, installation, product and support services)	$	376		$	447
Extended warranty contracts		2,061			2,082
Total deferred revenue		2,437			2,529
Less: long-term portion of deferred revenue		(355	)		(418	)
Deferred revenue — current	$	2,082		$	2,111

The Company’s revenues related to the following geographic areas were as follows (in thousands):

Information regarding revenues disaggregated by the timing of when goods and services are transferred is as follows (in thousands):


	Three Months Ended
	March 31,
	2023		2022
Revenue recognized over time	$	1,169	$	1,121
Revenue recognized at a point in time		9,298		9,045
Net revenue	$	10,467	$	10,166

The Company’s sales by end market were as follows (in thousands):